Key result
Vasoactive agents for perioperative hypotension were evaluated in 124 heterogeneous studies covering 18 agents and 88 distinct outcome measures, of which 54 were non-patient-centred.
Why the study?
Perioperative hypotension is common and linked to adverse outcomes, but the ideal vasoactive drug, dose, and treatment duration remain unestablished.
What is the current evidence regarding the use of vasoactive agents to treat perioperative hypotension in non-cardiac surgery?
What is the current evidence regarding the use of vasoactive agents to treat perioperative hypotension in non-cardiac surgery?
There is significant heterogeneity in the literature regarding the use of vasoactive agents for perioperative hypotension in non-cardiac surgery, highlighting a need for standardized, patient-centered outcome measures.
Varied evidence on vasoactive agents leaves perioperative hypotension management uncertain; highlights need for patient-centered RCTs.
BACKGROUND: Perioperative hypotension is common and associated with adverse patient outcomes. Vasoactive agents are often used to manage hypotension, but the ideal drug, dose and duration of treatment has not been established. With this scoping review, we aim to provide an overview of the current body of evidence regarding the vasoactive agents used to treat perioperative hypotension in non-cardiac surgery. METHODS: We included all studies describing the use of vasoactive agents for the treatment of perioperative hypotension in non-cardiac surgery. We excluded literature reviews, case studies, and studies on animals and healthy subjects. We posed the following research questions: (1) in which surgical populations have vasoactive agents been studied? (2) which agents have been studied? (3) what doses have been assessed? (4) what is the duration of treatment? and (5) which desirable and undesirable outcomes have been assessed? RESULTS: We included 124 studies representing 10 surgical specialties. Eighteen different agents were evaluated, predominantly phenylephrine, ephedrine, and noradrenaline. The agents were administered through six different routes, and numerous comparisons between agents, dosages and routes were included. Then, 88 distinct outcome measures were assessed, of which 54 were judged to be non-patient-centred. CONCLUSIONS: We found that studies concerning vasoactive agents for the treatment of perioperative hypotension varied considerably in all aspects. Populations were heterogeneous, interventions and exposures included multiple agents compared against themselves, each other, fluids or placebo, and studies reported primarily non-patient-centred outcomes.
No takes yet. Share an insight, caveat, or question.
Bækgaard et al. (2024) conducted a review in Perioperative hypotension in non-cardiac surgery. Vasoactive agents vs. Themselves, each other, fluids, or placebo was evaluated on Study characteristics including populations, agents, doses, duration of treatment, and outcomes assessed. Vasoactive agents for perioperative hypotension were evaluated in 124 heterogeneous studies covering 18 agents and 88 distinct outcome measures, of which 54 were non-patient-centred.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: